Africa Malaria Treatment Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Pharmaceutical Africa Malaria Treatment Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Africa Malaria Treatment Market Analysis

  • Pharmaceutical
  • Upcoming Report
  • Jan 2024
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
Buy Now Buy Now

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of AFRICA MALARIA TREATMENT MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market end user coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. AFRICA MALARIA TREATMENT MARKET: REGULATIONS
  6. Summary write-up (Africa)
  7. Pipeline analysis
  8. Market Overview
    1. Drivers
      1. High prevalence and disease burden of malaria in Africa
      2. Rise in medical insurance
      3. Humid climatic conditions and rising number of mosquitoES (Anopheles gambiae complex) in certain parts of Africa
    2. Restraints
      1. Adverse effects and risks associated with antimalariaL drugs
      2. Lack of awareness related to symptoms of malaria
      3. Low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment
    3. OpportunitIES
      1. strategic initiatives by major players
      2. increasing launch of new products
      3. Increase in production and export as well as import of hydroxychloroquine and chloroquine
    4. Challenges
      1. Regulatory challenges to antimalarial drug approval
      2. Achieving universal access
  9. COVID-19 IMPACT ON THE AFRICA MALARIA TREATMENT MARKET
    1. PRICE IMPACT
    2. IMPACT ON SUPPLY CHAIN
    3. IMPACT ON DEMAND
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. africa malaria treatment MARKET, By agent
    1. overview
    2. Plasmodium Falciparum
    3. P. Vivax
    4. P. Ovale
    5. P. Malariae
    6. P. Knowlelsi
  11. AFRICA MALARIA TREATMENT MARKET, By type
    1. overview
    2. medication
      1. Chloroquine
      2. Primaquine
      3. Artemisinin-Based Combination Therapy (ACT)
        1. ARTEMETHER–LUMEFANTRINE
        2. ARTESUNATE-AMODIAQUINE
        3. DIHYDROARTEMISININ-PIPERAQUINE
        4. OTHERS
      4. Quinine
      5. Hydroxychloroquine
      6. Mefloquine
      7. Non-Artemisinin Based Combinations (Non-ACTs)
        1. SULFADOXINE-PYRIMETHAMINE WITH CHLOROQUINE
        2. SULFADOXINE-PYRIMETHAMINE WITH AMODIAQUINE
        3. OTHERS
      8. Others
    3. vaccination
      1. Rts,S/As01
      2. Pfspz
      3. Others
  12. AFRICA MALARIA TREATMENT MARKET, By treatment type
    1. overview
    2. Suppressive Treatment
    3. Radical Treatment
  13. AFRICA MALARIA TREATMENT MARKET, By Drug Type
    1. overview
    2. generics
    3. branded
      1. Artefan
      2. Coartem
      3. Riamet
      4. Malarone
      5. Eurartesim
      6. Lonart
      7. Others
  14. AFRICA MALARIA TREATMENT MARKET, By route of administration
    1. overview
    2. oral
    3. Parenteral
      1. Intravenous
      2. Intramuscular
      3. Subcutaneous
  15. AFRICA MALARIA TREATMENT MARKET, By end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. Home Healthcare
    5. others
  16. AFRICA MALARIA TREATMENT MARKET, By distribution channel
    1. overview
    2. direct tender
    3. Hospital Pharmacies
    4. Retail Pharmacies
    5. Online Pharmacies
    6. Others
  17. Africa malaria treatment market, BY Country
    1. NIGERIA
    2. DEMOCRATIC REPUBLIC OF THE CONGO
    3. UGANDA
    4. NIGER
    5. CÔTE D’IVOIRE
    6. KENYA
    7. SOUTH AFRICA
    8. EGYPT
    9. REST OF AFRICA
  18. Africa MALARIA TREATMENT Market: COMPANY landscape
    1. company share analysis: Africa
  19. swot analysis
  20. company profile
    1. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. cipla inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. company share analysis
      4. product portfolio
      5. RECENT DEVELOPMENTS
    3. Strides Pharma Science Limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. Hikma Pharmaceuticals PLC
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. Recent development
    5. Sun Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. AJANTA PHARMA.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    7. Bliss GVS Pharma Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    8. GlaxoSmithKline plc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    9. Lupin Pharmaceuticals, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    10. MMV
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. sanofi-aventis U.S. LLC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    12. Taj Pharmaceuticals Limited
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    14. Zydus Cadila
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. Recent development
  21. questionnaire
  22. related reports

List of Table

TABLE 1 Africa malaria treatment Market, pipeline analysis

TABLE 2 ESTIMATED Malaria Cases and Deaths, by Region, 2018

TABLE 3 Regulatory Challenges to Antimalarial Drug Approval.

TABLE 4 Challenges and problems that drive the R&D framework

TABLE 5 AFRICA MALARIA TREATMENT MARKET, By Agent, 2019-2028 (USD thousand)

TABLE 6 Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 7 Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 8 Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 9 Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 10 Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 11 Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 12 Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 13 Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 14 Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 15 Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 16 Africa Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)

TABLE 17 Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 18 Africa Malaria treatment Market, By country, 2019-2028 (USD Thousand)

TABLE 19 Nigeria Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 20 Nigeria Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 21 Nigeria Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 22 Nigeria Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 23 Nigeria Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 24 Nigeria Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 25 Nigeria Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 26 Nigeria Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 27 Nigeria Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 28 Nigeria Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 29 Nigeria Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 30 Nigeria Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 31 Nigeria Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 32 Democratic Republic of the Congo Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 33 Democratic Republic of the Congo Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 34 Democratic Republic of the Congo Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 35 Democratic Republic of the Congo Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 36 Democratic Republic of the Congo Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 37 Democratic Republic of the Congo Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 38 Democratic Republic of the Congo Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 39 Democratic Republic of the Congo Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 40 Democratic Republic of the Congo Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 41 Democratic Republic of the Congo Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 42 Democratic Republic of the Congo Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 43 Democratic Republic of the Congo Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)

TABLE 44 Democratic Republic of the Congo Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 45 Uganda Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 46 Uganda Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 47 Uganda Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 48 Uganda Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 49 Uganda Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 50 Uganda Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 51 Uganda Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 52 Uganda Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 53 Uganda Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 54 Uganda Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 55 Uganda Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 56 Uganda Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 57 Uganda Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 58 Niger Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 59 Niger Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 60 Niger Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 61 Niger Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 62 Niger Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 63 Niger Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 64 Niger Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 65 Niger Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 66 Niger Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 67 Niger Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 68 Niger Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 69 Niger Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 70 Niger Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 71 Côte d’Ivoire Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 72 Côte d’Ivoire Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 73 Côte d’Ivoire Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 74 Côte d’Ivoire Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 75 Côte d’Ivoire Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 76 Côte d’Ivoire Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 77 Côte d’Ivoire Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 78 Côte d’Ivoire Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 79 Côte d’Ivoire Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 80 Côte d’Ivoire Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 81 Côte d’Ivoire Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 82 Côte d’Ivoire Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 83 Côte d’Ivoire Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 84 Kenya Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 85 Kenya Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 86 Kenya Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 87 Kenya Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 88 Kenya Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 89 Kenya Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 90 Kenya Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 91 Kenya Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 92 Kenya Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 93 Kenya Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 94 Kenya Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 95 Kenya Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 96 Kenya Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 97 South Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 98 South Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 99 South Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 100 South Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 101 South Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 102 South Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 103 South Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 104 South Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 105 South Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 106 South Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 107 South Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 108 South Africa Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 109 South Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 110 Egypt Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 111 Egypt Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 112 Egypt Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 113 Egypt Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 114 Egypt Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 115 Egypt Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 116 Egypt Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 117 Egypt Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 118 Egypt Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 119 Egypt Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 120 Egypt Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 121 Egypt Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 122 Egypt Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 123 Rest of Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

List of Figure

FIGURE 1 Africa malaria treatment MARKET: segmentation

FIGURE 2 AFRICA MALARIA TREATMENT MARKET: data triangulation

FIGURE 3 AFRICA MALARIA TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 AFRICA MALARIA TREATMENT MARKET: REGIONAL vs COUNTRY MARKET ANALYSIS

FIGURE 5 AFRICA MALARIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 AFRICA MALARIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 AFRICA MALARIA TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 AFRICA MALARIA TREATMENT MARKET: MARKET end user COVERAGE GRID

FIGURE 9 AFRICA MALARIA TREATMENT MARKET: vendor share analysis

FIGURE 10 AFRICA MALARIA TREATMENT MARKET: SEGMENTATION

FIGURE 11 increasing prevalence of MALARIA, RISING MEDICAL HEALTHCARE INSURANCE, AND humid climatic conditions in africa are expected to drive THE AFRICA MALARIA TREATMENT MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 Plasmodium Falciparum segment is expected to account for the largest share of the AFRICA MALARIA TREATMENT MARKET in 2021 and 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AFRICA MALARIA TREATMENT MARKET

FIGURE 14 Malaria Cases in 10 highest-burden countries in Africa, 2010-2017

FIGURE 15 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2020

FIGURE 16 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2019-2028 (USD thousand)

FIGURE 17 AFRICA MALARIA TREATMENT MARKET: By AGENT, CAGR (2021-2028)

FIGURE 18 AFRICA MALARIA TREATMENT MARKET: By AGENT, LIFELINE CURVE

FIGURE 19 AFRICA MALARIA TREATMENT MARKET: By type, 2020

FIGURE 20 AFRICA MALARIA TREATMENT MARKET: By type, 2019-2028 (USD thousand)

FIGURE 21 AFRICA MALARIA TREATMENT MARKET: By type, CAGR (2021-2028)

FIGURE 22 AFRICA MALARIA TREATMENT MARKET: By type, LIFELINE CURVE

FIGURE 23 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2020

FIGURE 24 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2019-2028 (USD thousand)

FIGURE 25 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, CAGR (2021-2028)

FIGURE 26 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, LIFELINE CURVE

FIGURE 27 AFRICA MALARIA TREATMENT MARKET: By drug type, 2020

FIGURE 28 AFRICA MALARIA TREATMENT MARKET: By drug type, 2019-2028 (USD thousand)

FIGURE 29 AFRICA MALARIA TREATMENT MARKET: By drug type, CAGR (2021-2028)

FIGURE 30 AFRICA MALARIA TREATMENT MARKET: By drug type, LIFELINE CURVE

FIGURE 31 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2020

FIGURE 32 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2019-2028 (USD thousand)

FIGURE 33 AFRICA MALARIA TREATMENT MARKET: By route of administration, CAGR (2021-2028)

FIGURE 34 AFRICA MALARIA TREATMENT MARKET: By route of administration, LIFELINE CURVE

FIGURE 35 AFRICA MALARIA TREATMENT MARKET: By end user, 2020

FIGURE 36 AFRICA MALARIA TREATMENT MARKET: By end user, 2019-2028 (USD thousand)

FIGURE 37 AFRICA MALARIA TREATMENT MARKET: By end user, CAGR (2021-2028)

FIGURE 38 AFRICA MALARIA TREATMENT MARKET: By end user, LIFELINE CURVE

FIGURE 39 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2020

FIGURE 40 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2019-2028 (USD thousand)

FIGURE 41 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 42 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 43 Africa Malaria treatment MARKET: SNAPSHOT (2020)

FIGURE 44 Africa Malaria treatment MARKET: BY COUNTRY (2020)

FIGURE 45 Africa Malaria treatment MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 Africa Malaria treatment MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 Africa Malaria treatment MARKET: BY Agent (2021-2028)

FIGURE 48 Africa MALARIA TREATMENT Market: company share 2020 (%)

Frequently Asked Questions

The market is segmented based on , By Agent (Plasmodium Falciparum, P.Vivax, P.Ovale, P.Malariae, P.Knowlelsi), Type (Medication, Vaccination, Others), Treatment Type (Suppressive Treatment, Radical Treatment), Drug Type (Generics, Branded), Route of Administration (Oral, Parenteral), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) – Industry Trends and Forecast to 2031. .
The Africa Malaria Treatment Market size was valued at USD 51.35 USD million in 2023.
The Africa Malaria Treatment Market is projected to grow at a CAGR of 6.4% during the forecast period of 2024 to 2031.
The market report covers data from the Nigeria, Democratic Republic of the Congo, Uganda, Niger, Côte d’Ivoire, Kenya, South Africa, Egypt, Rest of Africa.

Browse Related Pages

Banner